Logo

TriLink, Astral Scientific Forge Distribution Deal

Nov 15, 2011

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a distribution deal covering Australia with Astral Scientific for its nucleic acid products.

Products covered by the deal include more than 150 modified nucleotides, custom oligonucleotides, and CleanAmp Hot Start PCR products, San Diego-based TriLink said.

Financial terms of the deal were not disclosed.

Astral supplies core consumables to the clinical diagnostic, life science, and industrial markets.

Filed under

PCR
Molecular Diagnostics
TriLink
Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.